WIC
AVNS

Woodmont Investment Counsel’s Avanos Medical AVNS Stock Holding History

Woodmont Investment Counsel’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-620
Closed -$21K – 221
2016
Q3 		$21K Buy
+620
New +$21.7K 0.01% 360
2016
Q2 		– Sell
-632
Closed -$18K – 204
2016
Q1 		$18K Sell
632
-18
-3% -$480 0.01% 347
2015
Q4 		$22K Buy
650
+18
+3% +$560 0.01% 346
2015
Q3 		$18K Sell
632
-125
-17% -$4.36K 0.01% 353
2015
Q2 		$31K Buy
+757
New +$34K 0.01% 311

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Woodmont Investment Counsel's AVNS Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 620 shares — an estimated $21K sold.

Woodmont Investment Counsel first reported a position in AVNS in Q2 2015 and held it in 5 quarters. The position peaked at $31K in Q2 2015. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 620 Avanos Medical shares in Q4 2016, an estimated $21K.
  • Woodmont Investment Counsel first reported a position in Avanos Medical in Q2 2015 and held it in 5 quarters.
  • Woodmont Investment Counsel's Avanos Medical position peaked at $31K in Q2 2015.
  • 360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.